User Community

Advertisement

Cari - BioQC
@cari-bioqc
Active Member
Joined: Jun 23, 2025
Last seen: Jun 23, 2025
Topics: 0 / Replies: 5
Reply
RE: Number of replicates

First of all, we need to consider that the samples we analyse are just that: samples that should represent something bigger, such as the process, the ...

2 days ago
Reply
RE: Robustness

Guidelines ICH Q2 and ICH Q14 specify that robustness testing is part of method development, although many companies make it part of the method valida...

2 days ago
Reply
RE: Analytical Target Profile

I fully underline the previous answer, and you can also bring it back to a simpler question: if you do not know what the purpose of the method will be...

2 days ago
Reply
RE: CRO or Dossier Holder responsible for Specification

In addition to the previous answer: the so-called sponsor, the license-holding pharmaceutical company, has the overall responsibility for the quality ...

2 days ago
Reply
RE: Potency Testing

By the number of vies, this is an important topic. However, we also see no responses so far, perhaps indicating the question is too general. Could you...

2 days ago

Advertisement

Advertisement

Advertisement